NUVB Stock Ownership Activity

NUVATION BIO INC 13F holders

No value investing guru has made any change to the NUVATION BIO INC (NUVB) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying NUVB now?

According to the latest SEC filing(s) NUVATION BIO INC (NUVB) has not been purchased by any super investor.

To see more about who is investing in NUVATION BIO INC (NUVB), please go to the NUVB ownership page.

2023 Q1 (1 result)
Seth Klarman
-100.00%
-4,808,194
-0.16%
0.00%
Current price: $2.85 48.43% Reported price*: $1.92
2022 Q4 (1 result)
Seth Klarman
-53.85%
-5,610,000
-0.18%
0.00%
Current price: $2.85 48.43% Reported price*: $1.92
2022 Q2 (1 result)
Seth Klarman
-0.24%
-25,300
-0.00%
0.50%
Current price: $2.85 12.04% Reported price*: $3.24
2022 Q1 (1 result)
Seth Klarman
+21.11%
+1,820,473
+0.10%
0.59%
Current price: $2.85 45.82% Reported price*: $5.26
2021 Q2 (1 result)
David Einhorn
-76.67%
-115,005
-0.07%
0.02%
Current price: $2.85 69.41% Reported price*: $9.32
2021 Q1 (3 results)
David Abrams
buy
+3,811,513
+0.77%
0.77%
Seth Klarman
buy
+8,623,021
+0.66%
0.66%
David Einhorn
buy
+150,000
+0.11%
0.11%
Current price: $2.85 70.44% AVG reported price*: $9.64
8 of 8

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.